SCHEMBL23940767

SCHEMBL23940767

CCc1cc(O)cc(C)c1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 3/20 0.46
ESR1 P03372 2/20 0.43
LMNA P02545 2/20 0.41
CYTH2 Q99418 1/20 0.40
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 2/20 0.39
CHEK1 O14757 1/20 0.39
WEE1 P30291 1/20 0.39
KDM4E B2RXH2 3/20 0.38
ERAP1 Q9NZ08 1/20 0.38
EP300 Q09472 1/20 0.38
CREBBP Q92793 1/20 0.38
NPC1 O15118 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23940766 0.89 ESR2 (0.47) ESR2ESR1LMNAMAPTCHEK1
SCHEMBL11529244 0.82 CYP3A4 (0.42) ESR2ESR1ALDH1A1SMN1; SMN2GABRA1
SCHEMBL1513560 0.82 ESR2 (0.57) ESR2ESR1LMNACYTH2PPARG
SCHEMBL23940772 0.82 KDM4E (0.44) ESR2ESR1ALDH1A1MAPTCHEK1
SCHEMBL11414380 0.77 ESR1 (0.46) ESR2ESR1CHEK1WEE1SMN1; SMN2
SCHEMBL23941183 0.77 TSHR (0.51) LMNAALDH1A1MAPTKDM4ENPC1
SCHEMBL23940773 0.76 ESR2 (0.60) ESR2ESR1CYTH2ALDH1A1MAPT
SCHEMBL23925917 0.74 TSHR (0.53) LMNAALDH1A1MAPTKDM4ENPC1
SCHEMBL29287975 0.74 CNR2 (0.44) ESR2ESR1KDM4ESMN1; SMN2RCE1
SCHEMBL11296783 0.73 PTPN1 (0.42) ESR2ESR1ALDH1A1GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2023-04-20 US disclosed
WO-2021211982-A2 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS CYP2B6, TYR, CYP2D6 ESR2 756/4885ESR1 972/4885LMNA 2835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.